
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : Mass Ave Capital
Deal Size : $25.0 million
Deal Type : Financing
Details : The funds will enable the Company to advance its differentiated tissue-targeted Lipid Nanoparticle (ttLNP) technology to enable a new generation of highly targeted LNP-mRNA based genetic medicines.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
June 07, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : Mass Ave Capital
Deal Size : $25.0 million
Deal Type : Financing
